“Evidence-Based Prioritization and Scoring of Genomic Loci Interacting With Pioglitazone Therapeutic Response in Diabetic Patients”. Precision Medicine Communications, vol. 2, no. 2, Dec. 2022, pp. 91-108, https://doi.org/10.55627/pmc.002.02.0188.